Your tools can make or break your analysis, so we pitted the top B-cell receptor reconstruction tools against each other....

QIAGEN launches QCI Secondary Analysis, a new cloud-based secondary analysis solution for oncology and inherited disease applications that enables high-throughput...

  More mutations, better annotations, confident classifications HGMD Professional 2024.1 is now available, expanding the world’s largest collection of human...

How expert-curated cancer data from COSMIC and HSMD can help biopharmaceutical researchers identify and validate targets faster and optimize clinical...

What should you expect from your pathway analysis tools? When it comes to data-driven science, your results are only as...

How expert-curated cancer data from COSMIC and HSMD can help biopharmaceutical researchers identify and validate targets faster and optimize clinical...

As the cost of an individual genome becomes more attainable, laboratories in North America and Europe are experimenting with offering...

Will the hot topic of the decade survive the next ten years?

The latest release of COSMIC Actionability v11 adds 21 new curated genes and over 840 clinical trials The latest release...

Genome and exome sequencing is transforming cancer diagnostics and care. In the first installment of our Advancing Clinical NGS series,...